Explore the Future Direction of HIV-1 Latent Virus
DOI: 10.23977/medsc.2021.020201 | Downloads: 8 | Views: 1238
Author(s)
Jiaxin Liu 1
Affiliation(s)
1 Department of Biology, Baylor University, Waco, 76706, USA
Corresponding Author
Jiaxin LiuABSTRACT
Human immunodeficiency virus-1 (HIV-1) can be latent in quiescent CD4+ T cells, in which the viral DNA is silent in transcription and undetectable by the immune system. HIV-1 proviral DNA survives in the latent form primarily in quiescent CD4+ T cells. Although the current antiretroviral therapy (ART) can effectively inhibit the virus replication in HIV-1 infected people and suppress HIV to an undetectable level, ART does not work on latent HIV-1. Therefore, current ART cannot completely cure HIV-1 infected people, and HIV-1 infected people must use life-long ART to inhibit virus replication. Therefore, developing drugs that can act directly on latent HIV-1 is the biggest obstacle to the treatment of HIV-1 infection.
KEYWORDS
BRD4, HIV-1, Latency, Tat, ReactivationCITE THIS PAPER
Jiaxin Liu. Explore the Future Direction of HIV-1 Latent Virus. MEDS Clinical Medicine (2021) 2: 1-3. DOI: http://dx.doi.org/10.23977/medsc.2021.020201.
REFERENCES
[1] Dahabieh, Matthew S et al. “Understanding HIV latency: the road to an HIV cure.” Annual review of medicine, vol.66, no.03, pp.407-421, 2015.
Downloads: | 4288 |
---|---|
Visits: | 190702 |
Sponsors, Associates, and Links
-
Journal of Neurobiology and Genetics
-
Medical Imaging and Nuclear Medicine
-
Bacterial Genetics and Ecology
-
Transactions on Cancer
-
Journal of Biophysics and Ecology
-
Journal of Animal Science and Veterinary
-
Academic Journal of Biochemistry and Molecular Biology
-
Transactions on Cell and Developmental Biology
-
Rehabilitation Engineering & Assistive Technology
-
Orthopaedics and Sports Medicine
-
Hematology and Stem Cell
-
Journal of Intelligent Informatics and Biomedical Engineering
-
MEDS Basic Medicine
-
MEDS Stomatology
-
MEDS Public Health and Preventive Medicine
-
MEDS Chinese Medicine
-
Journal of Enzyme Engineering
-
Advances in Industrial Pharmacy and Pharmaceutical Sciences
-
Bacteriology and Microbiology
-
Advances in Physiology and Pathophysiology
-
Journal of Vision and Ophthalmology
-
Frontiers of Obstetrics and Gynecology
-
Digestive Disease and Diabetes
-
Advances in Immunology and Vaccines
-
Nanomedicine and Drug Delivery
-
Cardiology and Vascular System
-
Pediatrics and Child Health
-
Journal of Reproductive Medicine and Contraception
-
Journal of Respiratory and Lung Disease
-
Journal of Bioinformatics and Biomedicine